These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 22044321)
21. Application of standards for compounding. Newton DW J Am Vet Med Assoc; 1994 Jul; 205(2):232-4. PubMed ID: 7928584 [No Abstract] [Full Text] [Related]
22. Ruling gives FDA discretion in drug withdrawals. Cima G J Am Vet Med Assoc; 2014 Sep; 245(6):623. PubMed ID: 25322490 [No Abstract] [Full Text] [Related]
23. Dilemmas in compounding for the veterinary teaching hospital. Kemp DT J Am Vet Med Assoc; 1994 Jul; 205(2):263-7. PubMed ID: 7928595 [No Abstract] [Full Text] [Related]
24. The Home Field Disadvantage. Cabaleiro J Int J Pharm Compd; 2016; 20(1):86-7. PubMed ID: 27125059 [No Abstract] [Full Text] [Related]
25. HSUS sues FDA to end preventive extralabel use. Nolen S J Am Vet Med Assoc; 1999 Jun; 214(11):1607. PubMed ID: 10363086 [No Abstract] [Full Text] [Related]
26. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule. Food and Drug Administration, HHS Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859 [TBL] [Abstract][Full Text] [Related]
27. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view. Fink JL Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540 [No Abstract] [Full Text] [Related]
28. Pharmacy compounding: customizing prescription drugs. Nordenberg T FDA Consum; 2000; 34(4):11-2. PubMed ID: 11924628 [No Abstract] [Full Text] [Related]
29. Some compounding may be allowed, even if still illegal. J Am Vet Med Assoc; 2015 Jul; 247(1):25. PubMed ID: 26285314 [No Abstract] [Full Text] [Related]
30. Compounding for animal patients: contemporary issues. Lust E J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248 [TBL] [Abstract][Full Text] [Related]
31. Compounding forum: FDA-CVM hears veterinarians' views. J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690 [No Abstract] [Full Text] [Related]
32. Compliance Policy Guide on Chapter 4 Human Drugs: Section 460.200 Pharmacy Compounding. J Pain Palliat Care Pharmacother; 2003; 17(1):99-106. PubMed ID: 14640347 [No Abstract] [Full Text] [Related]
33. Compounding pharmacy oversight moves ahead. Traynor K Am J Health Syst Pharm; 2013 Jun; 70(11):920, 922, 924. PubMed ID: 23686593 [No Abstract] [Full Text] [Related]
34. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs. Patsner B Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473 [No Abstract] [Full Text] [Related]
35. FDA, states discuss pharmacy compounding regulatory framework. Traynor K Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976 [No Abstract] [Full Text] [Related]
36. Implications for the FDA/Center for Veterinary Medicine (CVM). Geyer RE J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592 [No Abstract] [Full Text] [Related]
37. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies. Hinkley KN State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443 [No Abstract] [Full Text] [Related]
38. Extralabel drug use policy revised: AVMA to send FDA comments on new antimicrobial order. Larkin M J Am Vet Med Assoc; 2012 Mar; 240(5):492-3. PubMed ID: 22435131 [No Abstract] [Full Text] [Related]
39. Veterinary compounding in small animals: a clinical pharmacologist's perspective. Boothe DM Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1129-73, viii. PubMed ID: 16984830 [TBL] [Abstract][Full Text] [Related]
40. Improving and enforcing compounding pharmacy practices to protect patients. Pegues DA Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]